EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, The Cooper's enterprise value is $20,607 Mil.
The Cooper's EBITDA for the trailing twelve months (TTM) ended in Jan. 2024 was $895 Mil. Therefore, The Cooper's EV-to-EBITDA for today is 23.03.
The historical rank and industry rank for The Cooper's EV-to-EBITDA or its related term are showing as below:
COO'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 12.86 Med: 21.94 Max: 35.46
Current: 23.03
During the past 13 years, the highest EV-to-EBITDA of The Cooper was 35.46. The lowest was 12.86. And the median was 21.94.
COO's EV-to-EBITDA is ranked worse than 71.11% of 488
companies
in the Medical Devices & Instruments industry
Industry Median: 14.625
vs COO: 23.03
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-04-19), The Cooper's stock price is $90.42.
The Cooper's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 was $1.463. Therefore, The Cooper's PE Ratio for today is 61.80.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
The Cooper EV-to-EBITDA Historical Data
The historical data trend for The Cooper's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, The Cooper's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Cooper EV-to-EBITDA Distribution
For the Medical Devices & Instruments industry and Healthcare sector, The Cooper's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where The Cooper's EV-to-EBITDA falls into.
The Cooper EV-to-EBITDA Calculation
The Cooper's EV-to-EBITDA for today is calculated as:
The Cooper's current Enterprise Value is $20,607 Mil.
The Cooper's EBITDA for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $895 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Cooper (NAS:COO) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The Cooper's share price for today is $90.42.
The Cooper's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.463.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of The Cooper's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
The Cooper Companies is one of the largest eye care companies in the U.S. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business and is composed of a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and clariti, Cooper controls roughly a quarter of the U.S. contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the U.S., and controls 17% of the U.S. IUD market.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
COO has been successfully added to your 